Effectiveness, adverse drug reactions and adherence among hypertension patients in department of general medicine at Integral Institute of Medical Science and Research: a prospective observational study

M. Sahil Mahfooz; Manauwar Husain; Mukul Roy; Kashefa Fatima; M. Sohel Akhter; M. Tauseef Khan

doi:10.18203/2319-2003.ijbcp20252571

Authors

M. Sahil Mahfooz Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
Manauwar Husain Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
Mukul Roy Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
Kashefa Fatima Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
M. Sohel Akhter Department of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
M. Tauseef Khan Department of General Medicine, Integral Institute of Medical Science and Research, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20252571

Keywords:

Antihypertensive therapy, Drug safety monitoring, Hypertension management, Real-world evidence, Treatment compliance

Abstract

Background: This study aimed to evaluate the drug effectiveness, adverse drug reactions and adherence among hypertensive patients. Additionally, we aimed to determine the clinical characteristics and the risk factors.

Methods: This six-month prospective observational study was jointly conducted by Integral University’s department of pharmacy and Medicine at Integral Institute of Medical Sciences and Research, Lucknow. The investigation involved 100 hypertensive patients from both inpatient (IPD) and outpatient (OPD) departments. Collected data were analysed through Microsoft Excel using descriptive statistical methods.

Results: The study population comprised 100 hypertensive patients (38 male, 62 female). Analysis showed 82% treatment efficacy, with telmisartan+amlodipine combination therapy achieving significant blood pressure reduction (11.7 mmHg). Notably, ADRs were monitored via active surveillance and patient interviews; suspected events were assessed using the Naranjo causality scale. Medication compliance reached 84%, particularly with once-daily regimens of amlodipine 5 mg and telmisartan 40 mg (marketed as Telvas/Telma). These findings demonstrate the clinical efficacy and safety profile of current antihypertensive protocols, emphasizing the importance of appropriate drug selection and dosing schedules.

Conclusions: The study confirmed the therapeutic effectiveness, strong adherence rates, and excellent safety profile of antihypertensive treatments, particularly telmisartan and amlodipine. These outcomes validate existing prescription patterns while providing real-world evidence for hypertension management strategies. Ongoing monitoring of treatment response and patient compliance remains crucial for maintaining optimal cardiovascular health outcomes.

Metrics

Metrics Loading ...

References

Chandra S, Kaur S, Jayabhaye D, Ubale A. Adverse drug reaction monitoring in patients of hypertension at a tertiary care hospital, Aurangabad, Maharashtra, India. Int J Basic Clin Pharmacol. 2021;10:720-5. DOI: https://doi.org/10.18203/2319-2003.ijbcp20212084

Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878-90. DOI: https://doi.org/10.1016/S0140-6736(23)00457-9

Svensson S, Kjellgren K. Adverse events and patients’ perceptions of antihypertensive drug effectiveness. J Hum Hypertens. 2003;17:671-5 DOI: https://doi.org/10.1038/sj.jhh.1001596

World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.

Park CL, Russell BS, Fendrich M, Finkelstein-Fox L, Hutchison M, Becker J. Americans’ COVID-19 stress, coping, and adherence to CDC guidelines. J Gen Intern Med. 2020;35(8):2296-303. DOI: https://doi.org/10.1007/s11606-020-05898-9

Mathes T, Pieper D, Antoine SL, Eikermann M. 50% adherence of patients suffering chronic conditions-where is the evidence? Ger Med Sci. 2012;10:Doc16.

Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-13. DOI: https://doi.org/10.1161/01.HYP.25.3.305

Wells BG. Pharmacotherapy handbook. 7th edn. The McGraw-Hill Companies; 2009.

de la Sierra A. New American and European Hypertension Guidelines, Reconciling the Differences. Cardiol Ther. 2019;8(2):157-66. DOI: https://doi.org/10.1007/s40119-019-0144-3

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-115. DOI: https://doi.org/10.1161/HYP.0000000000000065

Vrabie AM, Totolici S, Balahura AM, Weiss E, Japie C, Badila E. Secondary hypertension: an overview for the practitioner. J Hypertens Res. 2022;8(1):31-45.

Hegde S, Ahmed I, Aeddula NR. Secondary Hypertension. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025

Lima TD, Meiners MM, Soler O. Treatment adherence profile of hypertensive patients treated at the Fátima Municipal Health Unit, in Belém, Pará, Amazônia, Brazil. Pan-Amazon Health J. 2010;1(2):113-20. DOI: https://doi.org/10.5123/S2176-62232010000200014

Paz MA, de-La-Sierra A, Saez M, Barceló MA, Rodríguez JJ, Castro S, et al. Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement. Medicine. 2016;95(30):e4071. DOI: https://doi.org/10.1097/MD.0000000000004071

Asgedom SW, Atey TM, Desse TA. Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia. BMC Res Notes. 2018;11(1):27. DOI: https://doi.org/10.1186/s13104-018-3139-6

Hareri HA, Gedefaw M, Simeng B. Assessment of prevalence and associated factors of adherence to anti-hypertensive agents among adults on follow up in Adama Referral Hospital, East Shoa, Ethiopia: a cross-sectional study. Int J Curr Microbiol Appl Sci. 2014;3(1):760-70.

Jainaf Nachiya RA, Parimalakrishnan S, Ramakrishna Rao M. Study on drug utilization pattern of antihypertensive medications on out-patients and inpatients in a tertiary care teaching hospital: a cross sectional Study. Afr J Pharm Pharmacol. 2015;9(11):383-96. DOI: https://doi.org/10.5897/AJPP2014.4263